lentiviral service

For over a decade, QVirus Platform at Creative Biogene has always optimized our lentivirus production systems, including lentivirus plasmid construction and low endotoxin plasmid preparation, host cells for lentivirus packaging and lentivirus packaging process, cell culture medium, small and large scale lentivirus purification process. Thus, Our QVirus Platform can offer a comprehensive portfolio of products and services for the efficient design, development, manufacturing and analytical testing of lentivirus vector. So far, we have constructed, packaged, and purified thousands of lentiviruses for worldwide clients. If you have any special requirements, please feel free to contact us. lentiviral service https://qvirus.creative-biogene.com/solution/lentivirus.html

Viral vectors have been widely used as gene delivery vehicles. Compared to the conventional transfection methods, transduction usually results in much higher gene delivery efficiency, sometimes almost 100%. These are especially useful for gene delivery into primary cells or stem cells which is recalcitrant to conventional transfection methodologies. However, construction of a viral vector is a laborious process, and most commercial services in this area have so far been either too expensive or not user-friendly. With years of experience, Creative Biogene has launched a powerful QVirusTM Platform for Lentivirus, Retrovirus, Adeno-associated Virus (AAV), Adenoviruses, Retrovirus, Oncolytic virus, etc. viral vectors https://qvirus.creative-biogene.com/

Recombinant adeno-associated viral (rAAV) vectors have been used in over 200 clinical trials with a good safety profile and significant clinical benefit in a number of genetic diseases. Moreover, because of their ability to infect non-dividing and dividing cells and to act as an efficient substrate for homologous recombination, rAAVs are being used as a tool for gene-editing approaches. AAV testing https://qvirus.creative-biogene.com/solution/aav-testing-service.html

Viral vectors have a long track record in therapeutic gene delivery and intervention. Current efforts are starting to bear fruit, as more viral vector therapies are reaching the later stages of clinical development. Since the discovery of adeno-associated virus (AAV), a variety of serotypes and variants have been described and characterized, with AAV2 being the most widely studied. GMP AAV vectors https://qvirus.creative-biogene.com/solution/gmp-aav-vectors-production.html